Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. (Full Guidance (PDF))
Technology appraisals, TA256 – Issued: May 2012
NICE recommends rivaroxaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation (see below).
Who can have rivaroxaban?
You should be able to have rivaroxaban if you have atrial fibrillation without underlying heart valve disease and at least one of the following applies:
- you have congestive heart failure (when the heart doesn’t pump blood as well as it should)
- you have high blood pressure
- you are 75 or older
- you have diabetes
- you have had a stroke or transient ischaemic attack (mini stroke) in the past.